Silk Road Medical Stock Performance
| SILK Stock | USD 18.90 1.10 6.18% |
On a scale of 0 to 100, Silk Road holds a performance score of 7. The entity has a beta of 1.87, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Silk Road will likely underperform. Please check Silk Road's expected short fall, and the relationship between the maximum drawdown and rate of daily change , to make a quick decision on whether Silk Road's existing price patterns will revert.
Risk-Adjusted Performance
7 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Silk Road Medical are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite quite uncertain essential indicators, Silk Road disclosed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 6.18 | Five Day Return 7.63 | Year To Date Return 54.92 | Ten Year Return (47.76) | All Time Return (47.76) |
1 | Silk Road Medical Inc Reports Growth Amidst Increased Adoption of TCAR | 02/28/2024 |
2 | Silk Road Medical Stock Price Down 4.3 percent After Insider Selling | 03/06/2024 |
3 | Lucas W. Buchanan Sells 9,877 Shares of Silk Road Medical, Inc Stock | 03/07/2024 |
4 | Advancing Healthcare Access Genesis MedTech Teams Up with Silk Road Medical to Serve Patients affected by Carotid Artery Disease in China | 03/08/2024 |
5 | A Quick Guide to Luna Snow, the Marvel Heroine Youve Never Heard Of | 03/28/2024 |
6 | Armis Acquires Silk Security to Incorporate Best in Class Security Prioritization and Remediation into Armis Centrix | 04/17/2024 |
7 | All You Need to Know About Silk Road Medical Rating Upgrade to Buy | 04/23/2024 |
| Begin Period Cash Flow | 55.4 M |
Silk |
Silk Road Relative Risk vs. Return Landscape
If you would invest 1,513 in Silk Road Medical on January 31, 2024 and sell it today you would earn a total of 267.00 from holding Silk Road Medical or generate 17.65% return on investment over 90 days. Silk Road Medical is currently generating 0.3125% in daily expected returns and assumes 3.1969% risk (volatility on return distribution) over the 90 days horizon. In different words, 28% of stocks are less volatile than Silk, and 94% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Silk Road Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Silk Road's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Silk Road Medical, and traders can use it to determine the average amount a Silk Road's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0977
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | SILK | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.2 actual daily | 28 72% of assets are more volatile |
Expected Return
| 0.31 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average Silk Road is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Silk Road by adding it to a well-diversified portfolio.
Silk Road Fundamentals Growth
Silk Stock prices reflect investors' perceptions of the future prospects and financial health of Silk Road, and Silk Road fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Silk Stock performance.
| Return On Equity | -0.35 | ||||
| Return On Asset | -0.14 | ||||
| Profit Margin | (0.31) % | ||||
| Operating Margin | (0.30) % | ||||
| Current Valuation | 600.47 M | ||||
| Shares Outstanding | 39.17 M | ||||
| Price To Book | 4.71 X | ||||
| Price To Sales | 4.03 X | ||||
| Revenue | 177.13 M | ||||
| Gross Profit | 100.76 M | ||||
| EBITDA | (55.48 M) | ||||
| Net Income | (55.74 M) | ||||
| Cash And Equivalents | 108.87 M | ||||
| Cash Per Share | 3.09 X | ||||
| Total Debt | 84.63 M | ||||
| Debt To Equity | 1.37 % | ||||
| Current Ratio | 6.92 X | ||||
| Book Value Per Share | 3.86 X | ||||
| Cash Flow From Operations | (32.01 M) | ||||
| Earnings Per Share | (1.44) X | ||||
| Market Capitalization | 697.31 M | ||||
| Total Asset | 265.31 M | ||||
| Retained Earnings | (399.45 M) | ||||
| Working Capital | 210.55 M | ||||
About Silk Road Performance
To evaluate Silk Road Medical Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Silk Road generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Silk Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Silk Road Medical market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Silk's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 217.89 | 234.40 | |
| Return On Tangible Assets | (0.21) | (0.22) | |
| Return On Capital Employed | (0.25) | (0.26) | |
| Return On Assets | (0.21) | (0.22) | |
| Return On Equity | (0.37) | (0.35) |
Things to note about Silk Road Medical performance evaluation
Checking the ongoing alerts about Silk Road for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Silk Road Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Silk Road Medical had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 177.13 M. Net Loss for the year was (55.74 M) with profit before overhead, payroll, taxes, and interest of 100.76 M. | |
| Silk Road Medical currently holds about 108.87 M in cash with (32.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.09. | |
| Silk Road Medical has a frail financial position based on the latest SEC disclosures | |
| Over 94.0% of the company shares are owned by institutional investors | |
| Latest headline from zacks.com: All You Need to Know About Silk Road Medical Rating Upgrade to Buy |
- Analyzing Silk Road's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Silk Road's stock is overvalued or undervalued compared to its peers.
- Examining Silk Road's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Silk Road's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Silk Road's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Silk Road's stock. These opinions can provide insight into Silk Road's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Silk Road Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for Silk Stock analysis
When running Silk Road's price analysis, check to measure Silk Road's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Silk Road is operating at the current time. Most of Silk Road's value examination focuses on studying past and present price action to predict the probability of Silk Road's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Silk Road's price. Additionally, you may evaluate how the addition of Silk Road to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance |
Is Silk Road's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Silk Road. If investors know Silk will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Silk Road listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.44) | Revenue Per Share 4.565 | Quarterly Revenue Growth 0.18 | Return On Assets (0.14) | Return On Equity (0.35) |
The market value of Silk Road Medical is measured differently than its book value, which is the value of Silk that is recorded on the company's balance sheet. Investors also form their own opinion of Silk Road's value that differs from its market value or its book value, called intrinsic value, which is Silk Road's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Silk Road's market value can be influenced by many factors that don't directly affect Silk Road's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Silk Road's value and its price as these two are different measures arrived at by different means. Investors typically determine if Silk Road is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Silk Road's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.